Poster Abstract Session:
76. Vaccines: New and Novel
Thursday, October 27, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Pediatric ID, Adult ID

Presentations:
742
Clinical Development of the Takeda Norovirus VLP Vaccine Candidate.
Robert Bargatze, PhD ; Paul Mendelman, MD ; Astrid Borkowski, MD ; Jakob Cramer, MD ; Robert Goodwin, PhD ; Frank Baehner, MD
743
Immunogenicity of the Booster Dose of 2 Investigational Protein-based Pneumococcal Vaccine Formulations in Toddlers: a Phase II Randomized Trial
Roman Prymula, MD, PhD ; Leszek Szenborn, MD ; Sven-Arne Silfverdal, MD, PhD, MPH ; Jacek Wysocki, MD, PhD ; Piotr Albrecht, MD, PhD ; Magali Traskine, MSc ; Asparuh Gardev, MD ; Yue Song, MD, PhD ; Dorota Borys, MD
744
The dynamics of Staphylococcus aureus carriage and comparisons by age in two studies of an investigational S aureus 4-antigen vaccine (SA4Ag)
C. Buddy Creech, MD, MPH, FPIDS ; James Baber, MBChB, MPH ; C. Hal Jones, PhD ; Naglaa Mohamed, PhD ; Dorota Jamrozy, PhD ; Li Hao, PhD ; Matthew Holden, PhD ; Paulina Carlson, BS ; Julian Parkhill, FMedSCi ; Sharon Peacock, PhD FRCP FRCPath ; Robert W. Frenck Jr., MD, FIDSA ; Joseph M. Severs, MS ; Joseph J. Eiden, MD, PhD ; Kathrin U. Jansen, PhD ; Alejandra Gurtman, MD ; Annaliesa S. Anderson, PhD
745
Safety and Reactogenicity of the Booster Dose of 2 Investigational Protein-based Pneumococcal Vaccine Formulations in Toddlers: a Phase II Randomized Trial
Roman Prymula, MD, PhD ; Leszek Szenborn, MD ; Sven-Arne Silfverdal, MD, PhD, MPH ; Jacek Wysocki, MD, PhD ; Piotr Albrecht, MD, PhD ; Magali Traskine, MSc ; Asparuh Gardev, MD ; Yue Song, MD, PhD ; Dorota Borys, MD
746
THREE YEAR FOLLOW UP FOR SAFETY AND IMMUNOGENICITY OF A CANDIDATE CLOSTRIDIUM DIFFICILE TOXOID VACCINE
Guy De Bruyn, MBBCh, MPH ; Richard Glover, MD ; Terry L. Poling, MD ; Xiaohua Sheng, PhD ; Dhaval Patel, PhD ; Patricia Pietrobon, PhD ; Richard Gesser, MD
747
Evaluating Sm-p80 Vaccine Cross-Species Protection againstĀ Schistosoma haematobiumĀ in Hamsters
Laura Johnson, . ; Afzal Siddiqui, PhD ; Adebayo Molehin, PhD ; Weidong Zhang, PhD ; Juan Rojo, BS
Posters
  • IDSA Poster Revised.pdf (1.2 MB)
  • 748
    Infectious Events Among Unvaccinated Participants in the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)
    Olamide Jarrett, MD, MPH ; Augustin Fombah, MBChB ; Radcliffe Lisk, MBBS, FRCP, FWACP, DTM&H
    749
    Strategies to Maximize Participant Retention in the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)
    Rosalind J. Carter, PhD ; Reynold B.G Senesi, MSc ; Samuel A. S. Kargbo, MBBS
    751
    Randomized, Phase III Clinical Trial to Assess the Immunogenicity and Safety of an Investigational Subunit Adjuvanted Herpes Zoster Vaccine Co-Administered with a Seasonal Quadrivalent Inactivated Influenza Vaccine in Adults Aged 50 Years and Older
    Tino F. Schwarz, PhD, MD ; Naresh Aggarwal, MBBS, FCFP ; Beate Moeckesch, MD ; Isabelle Schenkenberger, MD ; Carine Claeys, MD ; Olivier Godeaux, MD MPH ; Katrijn Grupping, PhD ; Thomas C. Heineman, MD, PhD ; Lidia Oostvogels, MD ; Peter Van Den Steen, PhD ; Himal Lal, MD
    Posters
  • Poster 751 - Tino Schwarz.pdf (345.4 kB)
  • 752
    No increased risk of herpes zoster after concomitant administration of zoster vaccine and pneumococcal polysaccharide vaccine
    Hung Fu Tseng, Ph.D., MPH ; Yi Luo, MS ; Lina Sy, MPH ; Sara Tartof, PhD, MPH ; Rulin Hechter, MD, PhD ; Steven Jacobsen, MD, PhD
    754
    Immunogenicity of Investigational 2-Dose Hepatitis B Vaccine, HEPLISAV-B, Compared with a Licensed Vaccine (ENGERIX-B) in Adults with Factors that Reduce Immune Responses
    Sam Jackson, MD ; Kim Erby, BS ; Lalith Akella, MS ; William L. Heyward, MD, MPH ; Randy Hyer, MD, PhD ; Robert Janssen, MD

    CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.